1,673 material Form 8-K filings that 1,260 companies we cover made with the SEC in February 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Where Food Comes From reported fourth-quarter and full-year 2025 results, with revenue and profit both lower than in 2024. Full-year total revenue fell to $24.9 million from $25.7 million and diluted EPS fell to $0.30 from $0.40, while the fourth quarter swung to a net loss. The filing furnishes the February 26, 2026 earnings press release and conference call transcript, which attribute the decline mainly to lower beef-related verification activity.
Full-year 2025 total revenue was $24.9 million vs. $25.7 million in 2024; diluted EPS was $0.30 vs. $0.40.
Fourth-quarter 2025 net loss of $0.2 million ($0.04 per diluted share) vs. net income of $1.0 million ($0.18) a year earlier.
Full-year net income included a $946,000 gain on sale of assets; cash from operations was $1.6 million vs. $2.7 million.
The company bought back 183,016 shares in 2025 and expects to continue repurchasing stock in 2026.
Arbor Realty Trust reported fourth-quarter 2025 net income of $14.6 million, or $0.07 per diluted share, down from $59.8 million, or $0.32, a year earlier. Full-year net income was $107.4 million, or $0.56 per diluted share, versus $1.18 in 2024. The board declared a $0.30 quarterly dividend, down from $0.43 declared in the fourth quarter of 2024.
Q4 2025 net income of $14.6 million, or $0.07 per diluted share, versus $0.32 in Q4 2024
Q4 2025 distributable earnings of $41.2 million, or $0.19 per diluted share, versus $0.40 in Q4 2024
Full-year 2025 net income of $107.4 million, or $0.56 per diluted share, versus $1.18 in 2024
Dividend of $0.30 per share payable March 24, 2026 to holders of record on March 10, 2026
Alpha Metallurgical Resources reported a fourth-quarter 2025 net loss of $17.3 million, or $1.34 per diluted share, compared with a $5.5 million loss in the third quarter and a $2.1 million loss a year earlier. For full-year 2025, the company posted a net loss of $61.7 million, or $4.75 per diluted share, after net income of $187.6 million in 2024, so shareholders are seeing a sharp reversal in profitability.
Q4 2025 net loss of $17.3 million ($1.34 per diluted share) vs. a $2.1 million loss in Q4 2024
Adjusted EBITDA of $28.5 million in Q4 2025, down from $41.7 million in Q3 2025 and $53.2 million in Q4 2024
Full-year 2025 total revenues of $2.13 billion vs. $2.96 billion in 2024
As of February 20, 2026, about 6.9 million shares repurchased for about $1.1 billion under a $1.5 billion authorization
CubeSmart reported fourth-quarter 2025 results on February 26, 2026, with diluted EPS down to $0.34 from $0.45 and FFO, as adjusted, per diluted share down 5.9% to $0.64. For the full year, diluted EPS fell to $1.46 from $1.72. The company also gave initial 2026 guidance of $1.55 to $1.63 in diluted EPS and $2.52 to $2.60 in FFO, as adjusted, per share, which shareholders can compare with 2025 results.
Q4 2025 net income attributable to common shareholders was $78.7 million, compared with $101.9 million in Q4 2024.
Same-store net operating income decreased 1.1% in Q4 2025, with same-store revenues down 0.1% and operating expenses up 2.9%.
2026 guidance: diluted EPS of $1.55 to $1.63 and FFO, as adjusted, per diluted share of $2.52 to $2.60; the filing does not state a prior guidance range.
Amphastar reported fourth-quarter and full-year 2025 results on February 26, 2026. Revenue, GAAP net income and diluted EPS declined from 2024 in both periods, and the release does not include financial guidance for 2026. Full-year results include a $23.1 million litigation provision, and glucagon sales fell 45% in the fourth quarter on lower average selling prices and unit volumes.
Q4 2025 net revenues were $183.1 million, down 2% from $186.5 million in Q4 2024
Q4 GAAP diluted EPS was $0.51 vs. $0.74; adjusted non-GAAP diluted EPS was $0.73 vs. $0.92
Full-year 2025 net revenues were $719.9 million vs. $732.0 million; GAAP diluted EPS was $2.03 vs. $3.06
BAQSIMI sales rose 46% to $185.4 million for the full year, while glucagon sales fell 36% to $69.1 million
Nexstar reported fourth-quarter 2025 net revenue of $1.29 billion, down 13.4% from a year earlier, mainly due to lower political advertising. The company posted a net loss of $170 million, compared with net income of $229 million a year earlier, after a $381 million impairment of its TV Food Network stake. It also issued 2026 standalone Adjusted EBITDA guidance of $1.95 billion to $2.05 billion.
Fourth-quarter advertising revenue was $549 million, down 27.6%; political advertising fell $233 million to $21 million.
Fourth-quarter Adjusted EBITDA was $433 million, down 31.1%, with margin of 33.6% versus 42.2%.
Full-year 2025 net revenue was $4.95 billion, down 8.5%, and net income was $83 million versus $683 million.
The proposed $6.2 billion TEGNA acquisition is anticipated to close by the second half of 2026, subject to regulatory approvals.
Papa John's reported fourth quarter and full year 2025 results on February 26, 2026. Net income and diluted EPS fell sharply from 2024, while total revenues were flat for the year, and the company introduced 2026 guidance that calls for adjusted EBITDA of $200 million to $210 million, compared with $201 million in 2025.
Q4 2025 diluted EPS was $0.21 versus $0.44 a year earlier; Q4 total revenues were $498.2 million, down 6.1%.
Full year 2025 diluted EPS was $0.90 versus $2.54 in 2024; total revenues were $2.1 billion, flat year over year.
2026 outlook: North America comparable sales down 2% to 4%, International comparable sales up 2% to 4%, and adjusted EBITDA of $200 million to $210 million.
The Board declared a first quarter 2026 dividend of $0.46 per common share.
United Parks & Resorts reported fourth-quarter 2025 revenue of $373.5 million, down 2.8%, and net income of $15.1 million, down 46%, which included a one-time non-cash bad debt write-off of $7.6 million. For fiscal 2025, revenue was $1.7 billion, down 3.6%, and net income was $168.4 million, down 26.0%. CEO Marc Swanson said results did not meet expectations and pointed to cost management and 2026 attendance initiatives.
Q4 2025 attendance was 4.8 million guests, down 2.6%, while in-park per capita spending rose 2.1% to a record $35.89.
Q4 2025 diluted EPS was $0.28 versus $0.50 a year earlier; adjusted EBITDA was $115.2 million, down 20.3%.
Fiscal 2025 diluted EPS was $3.06 versus $3.79; adjusted EBITDA was $605.1 million, down 13.6%.
The company repurchased about 6.7 million shares in 2025 and through February 24, 2026, about 12% of shares outstanding.
Perrigo reported fourth-quarter 2025 net sales of $1.11 billion, down 2.5% year over year, and a reported net loss of $1.41 billion, or $(10.20) per share, driven mainly by a $1.3 billion goodwill impairment. Adjusted EPS fell to $0.77 from $0.93, and the company's FY2026 'All In' adjusted diluted EPS outlook of $2.00 to $2.30 is below the FY2025 adjusted EPS of $2.75.
Q4 2025 net sales were $1.11 billion, down 2.5%; organic net sales fell 4.5%, with infant formula a key drag.
Reported Q4 EPS was $(10.20) versus $(0.30) a year earlier, due primarily to the $1.3 billion goodwill impairment.
FY2026 'All In' net sales outlook is -5.5% to -1.5%; the 'CORE' adjusted EPS outlook is $2.25 to $2.55 versus FY2025 CORE adjusted EPS of $2.52.
The company plans a two-year operational enhancement program with about 7% workforce reduction and $80 million to $100 million in pre-tax annualized savings by the end of FY2027.
Cactus reported fourth quarter 2025 revenue of $261.2 million, down from $272.1 million a year earlier, and diluted EPS of $0.57 versus $0.68. Management expects softer first quarter 2026 revenue in its legacy Pressure Control and Spoolable Technologies businesses, and director Melissa Law will not stand for re-election at the 2026 annual meeting.
Q4 2025 revenue was $261.2 million, down from $272.1 million in Q4 2024 and $264.0 million in Q3 2025.
Q4 2025 net income was $48.3 million versus $57.4 million a year earlier; diluted EPS was $0.57 versus $0.68.
Management expects Q1 2026 sales in legacy Pressure Control to soften and Spoolable Technologies revenue to be softer than Q4 2025.
Director Melissa Law advised on February 22, 2026 that she will not stand for re-election; the company says this is not due to any disagreement.
Chord Energy reported fourth-quarter and full-year 2025 results on February 25, 2026. Q4 net income was $84.4 million, down from $210.6 million a year earlier, and total revenues also declined, although production and capital spending came in at or better than guidance. The company kept its 2026 volume and capital guidance consistent with its November outlook and declared a $1.30 per share base dividend.
Q4 2025 net income was $84.4 million versus $210.6 million in Q4 2024; diluted EPS was $1.48 versus $3.43.
Q4 2025 total revenues were $1.17 billion versus $1.45 billion a year earlier; oil, NGL and gas revenues were $876.6 million.
2026 guidance: oil volumes of 157 to 161 MBopd and CapEx of $1.35 billion to $1.45 billion, consistent with the November outlook.
Base dividend of $1.30 per share is payable March 27, 2026 to shareholders of record as of March 12, 2026.
Green Brick Partners reported fourth-quarter and full-year 2025 results on February 25, 2026. Profit declined from a year earlier: fourth-quarter diluted EPS was $1.78 versus $2.31, and full-year diluted EPS was $7.07 versus $8.45, while full-year total revenues were flat at about $2.10 billion. The company also adopted a new $150 million share repurchase plan.
Q4 2025 net income attributable to Green Brick was $78.4 million, or $1.78 per diluted share, versus $103.8 million, or $2.31, in Q4 2024.
Q4 2025 total revenues were $552.6 million, down 2.6%, while 1,038 new homes were delivered, up 1.9%.
Full-year 2025 net income attributable to Green Brick was $313.2 million, or $7.07 per diluted share, versus $381.6 million, or $8.45, in 2024.
Full-year 2025 homebuilding gross margin was 30.5%, down from 33.8%, and the company adopted a new $150 million share repurchase plan.
Veeco reported fourth-quarter 2025 revenue of $165.0 million, down from $182.1 million a year earlier, and GAAP net income of $1.1 million, or $0.02 per diluted share, versus $15.0 million, or $0.26, in the prior-year quarter. For fiscal 2026 it guided to revenue of $740 million to $800 million and GAAP diluted EPS of $0.83 to $1.17, while the pending merger with Axcelis continues.
Q4 2025 non-GAAP EPS was $0.24, versus $0.41 in Q4 2024; Q4 2025 merger costs were $6.3 million
Full-year 2025 revenue was $664.3 million, versus $717.3 million in 2024; GAAP diluted EPS was $0.59, versus $1.23
Q1 2026 guidance: revenue of $150 million to $170 million and GAAP diluted EPS of ($0.03) to $0.07
The company cited a planned merger with Axcelis as part of its growth outlook
Protagonist reported fourth-quarter 2025 license and collaboration revenue of $7.4 million, down from $170.6 million a year earlier, and a net loss of $44.4 million, or $0.69 per share, compared with net income of $131.7 million in the prior-year quarter. For the full year, revenue fell to $46.0 million and the net loss was $130.1 million, and the company said the decline reflects lower, highly variable milestone revenue.
Q4 2025 license and collaboration revenue was $7.4 million, versus $170.6 million in Q4 2024, a decrease of $163.2 million.
Q4 2025 net loss was $44.4 million, or $0.69 per share, versus net income of $131.7 million, or $2.11 per basic share, a year earlier.
Full-year 2025 net loss was $130.1 million, or $2.05 per share, compared with net income of $275.2 million in 2024.
Cash, cash equivalents and marketable securities were $646.0 million at December 31, 2025, which the company expects to fund operations through at least the end of 2028.
Arcus Biosciences reported fourth-quarter and full-year 2025 results on February 25, 2026. Revenue declined and the net loss widened for both periods, and the company gave 2026 GAAP revenue guidance of $45 million to $55 million. Arcus and Gilead are winding down the Phase 3 STAR-221 and Phase 2 EDGE-Gastric studies, and the company expects R&D expenses to decrease meaningfully in 2026.
Full-year 2025 revenue was $247 million, down from $258 million in 2024; net loss was $353 million, or $3.29 per share, versus $283 million, or $3.14 per share in 2024
Fourth-quarter 2025 revenue was $33 million, down from $36 million; net loss was $106 million, compared with $94 million a year earlier
Company expects GAAP revenue of $45 million to $55 million for full-year 2026
Cash, cash equivalents and marketable securities were $1.0 billion at December 31, 2025, versus $992 million a year earlier, with funding expected until at least the second half of 2028
Alkermes reported that 2025 total revenues fell to $1.48 billion from $1.56 billion in 2024, and GAAP net income dropped to $242 million from $367 million. The company projected a 2026 GAAP net loss of $115 million to $135 million, with total revenues of $1.73 billion to $1.84 billion, after completing its Avadel acquisition on February 12, 2026. For shareholders, the results show lower 2025 revenue and profit, and the company expects a loss in 2026.
FY2025 total revenues were $1.48 billion versus $1.56 billion in FY2024; diluted GAAP EPS was $1.43 versus $2.17.
Q4 2025 GAAP net income was $49.3 million versus $146.5 million in Q4 2024.
2026 expectations: total revenues of $1.73 billion to $1.84 billion and GAAP net loss of $115 million to $135 million.
Avadel acquisition closed February 12, 2026, funded with about $775 million of balance sheet cash and term loans totaling $1.525 billion due in 2031.
Matador Resources reported fourth-quarter 2025 net income of $192.5 million, down from $214.5 million a year earlier, and diluted EPS of $1.55 versus $1.71, while daily production reached a company record of 211,290 BOE. The company also gave 2026 guidance calling for oil production of 122,000 to 124,000 barrels per day and total D/C/E and midstream capital spending of $1.45 billion to $1.55 billion, a reduction of about 11% from 2025.
Q4 2025 oil and natural gas revenues were $702.8 million, down from $893.9 million in Q4 2024.
Q4 2025 adjusted EPS was $0.87, compared with $1.83 in Q4 2024 and $1.36 in Q3 2025.
2026 guidance: oil production of 122,000 to 124,000 Bbl/d, about 3% above 2025 actual production of 119,723 Bbl/d.
2025 shareholder returns totaled $218.9 million, including $163.1 million in dividends and $55.8 million in share repurchases.
Expeditors International reported fourth-quarter 2025 results that declined from the same quarter of 2024, with diluted EPS down 11% to $1.49 and revenue down 3% to $2.9 billion. The company said ocean rates fell sharply and may remain soft in 2026, and its Board approved a new share repurchase program of up to $3 billion, which takes effect when the current program ends at 130 million outstanding shares.
Diluted EPS was $1.49 versus $1.68 a year earlier, down 11%; net earnings attributable to shareholders were $201 million, down 15%.
Operating income fell 17% to $251 million; ocean revenue per container fell 41% compared with the fourth quarter of 2024.
For full-year 2025, diluted EPS rose 4% to $5.95 and the company returned $875 million through dividends and share repurchases.
The Board authorized a new share repurchase program of up to $3 billion on February 23, 2026, effective when the current program expires at 130 million outstanding shares.
NexPoint Residential Trust reported a 2025 net loss attributable to common stockholders of $32.0 million, or $1.26 per diluted share, compared with net income of $1.1 million in 2024, as full-year revenue fell to $251.3 million from $259.7 million. It also issued initial 2026 guidance for a net loss of $1.26 to $1.54 per diluted share and Core FFO of $2.42 to $2.71 per diluted share, against $2.79 in 2025, which points to lower Core FFO for shareholders if the guidance holds.
Full-year 2025 net loss attributable to common stockholders was $32.0 million, or $1.26 per diluted share, versus net income of $1.1 million, or $0.04 per share, in 2024.
Total revenues were $251.3 million for 2025 versus $259.7 million in 2024; fourth-quarter revenues were $62.1 million versus $63.8 million.
Fourth-quarter 2025 net loss was $10.3 million, or $0.41 per share, versus $26.9 million, or $1.06 per share, a year earlier; Core FFO was $0.65 per diluted share versus $0.68.
2026 initial guidance: loss of $1.26 to $1.54 per diluted share and Core FFO of $2.42 to $2.71 per diluted share; Same Store NOI growth of -2.5% to 1.5%.
Westlake reported a fourth-quarter 2025 net loss of $544 million, or $4.22 per share, compared with net income of $7 million, or $0.06 per share, a year earlier. Excluding $511 million of identified items, mainly plant shutdown expenses, the loss was $33 million, or $0.25 per share, and EBITDA was $196 million versus $416 million a year earlier. Management said it expects 2026 earnings to improve, targeting $600 million of EBITDA benefit from its PEM profitability plan.
Q4 2025 net sales were $2.5 billion, down 11% year over year, with sales volume down 7% and average sales price down 4%.
Q4 2025 net loss was $544 million, or $4.22 per share; excluding identified items, the loss was $33 million, or $0.25 per share.
Full-year 2025 net loss was $1.5 billion, or $11.70 per share, including a $727 million goodwill write-off; excluding identified items, the loss was $116 million, or $0.90 per share.
Management targets $600 million of EBITDA improvement in 2026 from the PEM profitability plan, and cites the January 2026 acquisition of ACI.
AdaptHealth reported fourth-quarter 2025 net revenue of $846.3 million, down 1.2%, and a net loss attributable to the company of $102.8 million, compared with net income of $50.3 million a year earlier. The loss includes a non-cash goodwill impairment charge of $128.0 million, and Adjusted EBITDA fell 18.7% to $163.1 million. The company also issued 2026 guidance of $3.44 billion to $3.51 billion in net revenue and $680 million to $730 million in Adjusted EBITDA.
Q4 2025 net revenue was $846.3 million, down from $856.6 million; Adjusted EBITDA was $163.1 million, down from $200.6 million.
Q4 2025 net loss attributable to AdaptHealth was $102.8 million, including a $128.0 million non-cash goodwill impairment tied to the Diabetes Health unit.
Full-year 2025 net loss attributable to AdaptHealth was $70.8 million, versus net income of $90.4 million in 2024.
2026 guidance: net revenue of $3.44 billion to $3.51 billion, Adjusted EBITDA of $680 million to $730 million, and free cash flow of $175 million to $225 million.
Tennant Company reported fourth-quarter and full-year 2025 results with a fourth-quarter net loss of $4.4 million, tied to disruption from its North America ERP system go-live. Full-year 2025 net sales and adjusted EBITDA came in below the company's prior guidance ranges, and net income fell 47.7% from 2024. The company also forecast 2026 net sales of $1,240 million to $1,280 million and expects margins to improve gradually through the year, with a weaker first quarter.
Q4 2025 net sales were $291.6 million, down 11.3% from $328.9 million; net loss was $4.4 million, or $0.23 per diluted share, versus net income of $6.6 million a year earlier
Full-year 2025 net sales of $1,203.5 million fell below the $1.21 billion to $1.25 billion guidance range; adjusted EBITDA of $167.4 million fell below the $196 million to $209 million range
The company estimates the ERP disruption reduced Q4 2025 net sales by roughly $30 million and adjusted EBITDA by about $22 million
2026 guidance includes net sales of $1,240 million to $1,280 million and diluted EPS of $4.05 to $4.65; a two-week manufacturing shutdown in early January will significantly affect first-quarter sales and costs
Helix Energy Solutions Group reported fourth-quarter 2025 revenue of $334.2 million and net income of $8.3 million, or $0.06 per diluted share, both down from a year earlier. The quarter included an approximately $18.1 million non-cash impairment on the Thunder Hawk field, and full-year 2025 net income fell to $30.8 million from $55.6 million. The company ended 2025 with $445.2 million in cash and cash equivalents, but the filing gives no earnings guidance for 2026 and management expects the near-term market to continue at its current pace.
Q4 2025 revenue was $334.2 million, down from $355.1 million in Q4 2024 and $377.0 million in Q3 2025.
Q4 2025 net income was $8.3 million, or $0.06 per diluted share, versus $20.1 million, or $0.13, a year earlier, after an approximately $18.1 million pre-tax impairment.
Full-year 2025 net income was $30.8 million, or $0.21 per diluted share, versus $55.6 million, or $0.36, in 2024.
Full-year 2025 free cash flow was $120.4 million versus $163.2 million in 2024; cash and cash equivalents were $445.2 million at December 31, 2025.
Innovative Industrial Properties reported fourth-quarter 2025 total revenues of $66.7 million, down 13.1% from $76.7 million a year earlier, driven mainly by lower rental revenue tied to tenant defaults. Q4 net income attributable to common stockholders fell to $30.7 million, or $1.06 per diluted share, from $39.5 million, or $1.36, and AFFO per diluted share fell to $1.88 from $2.22. For shareholders, the quarter shows lower earnings and cash flow measures, while the company says it has raised capital and resolved some tenant matters.
Q4 2025 total revenues were $66.7 million, versus $76.7 million in Q4 2024, a decrease of 13.1%.
Full-year 2025 revenues were $266.0 million, and net income attributable to common stockholders was $114.4 million, or $3.93 per diluted share.
A quarterly dividend of $1.90 per common share was paid on January 15, 2026.
Brighthouse Financial reported fourth-quarter 2025 net income available to shareholders of $112 million, or $1.93 per diluted share, down from $646 million, or $10.79 per diluted share, a year earlier. Adjusted earnings, less notable items, were $227 million, or $3.93 per diluted share, compared with $352 million, or $5.88 per diluted share, in the fourth quarter of 2024. The company is being acquired by Aquarian Capital for $70.00 per share in cash, and shareholders approved the merger on February 12, 2026.
Q4 2025 net income available to shareholders was $112 million ($1.93 per diluted share), versus $646 million ($10.79) in Q4 2024
Q4 2025 adjusted earnings were $214 million ($3.70 per diluted share), versus $304 million ($5.07) in Q4 2024
Full-year 2025 net income available to shareholders was $331 million ($5.71 per diluted share), up from $286 million ($4.64) in 2024
Full-year 2025 adjusted earnings, less notable items, were $931 million ($16.07 per diluted share), down from $1,209 million ($19.63) in 2024
UFP Industries reported fourth-quarter 2025 net sales of $1.33 billion, down 9 percent from a year earlier, with diluted earnings per share of $0.70 against $1.12. The company said demand remains soft and expects 2026 overall demand to be flat to slightly down in each segment, so lower sales and profit are the key shareholder takeaway.
Q4 net sales $1.33 billion, down 9 percent, driven by a 7 percent decline in organic units and a 2 percent price decrease
Diluted EPS $0.70 vs $1.12; net earnings attributable to controlling interests $40 million vs $68 million
Adjusted EBITDA $107.2 million, or 8.1 percent of net sales, vs 9.1 percent a year ago
Quarterly dividend increased to $0.36 per share, payable March 16, 2026; 2025 share repurchases of nearly $450 million
Boise Cascade reported fourth quarter 2025 net income of $8.7 million, or $0.24 per diluted share, on sales of $1.5 billion, down from $68.9 million, or $1.78 per share, a year earlier. For full year 2025, net income fell 65% to $132.8 million, or $3.53 per share, as sales declined 5% to $6.4 billion. The company also said CEO Nate Jorgensen plans to retire and that Jeff will succeed him, a leadership change shareholders will track.
Fourth quarter net income was $8.7 million, or $0.24 per diluted share, versus $68.9 million, or $1.78 per share, in fourth quarter 2024.
Full year 2025 net income was $132.8 million, or $3.53 per share, versus $376.4 million, or $9.57 per share, in 2024.
A legal proceedings accrual in the Building Materials Distribution segment reduced fourth quarter and full year earnings by approximately $6 million, or $0.16 per share after tax.
CEO Nate Jorgensen is retiring, and Jeff is set to become CEO.
Apple Hospitality REIT reported fourth quarter and full year 2025 results on February 23, 2026. For the full year, net income fell 18.1% to $175.4 million and net income per share fell 16.9% to $0.74, while Comparable Hotels RevPAR declined 1.6%. The company's 2026 guidance calls for net income of $133 million to $160 million, a range below the 2025 result, and a Comparable Hotels RevPAR change of negative 1.00% to positive 1.00%.
Full year 2025 net income was $175.4 million, down 18.1% from $214.1 million in 2024; net income per share was $0.74, down 16.9%.
Fourth quarter 2025 net income was $29.6 million, down 0.7%, while net income per share was $0.13, up 8.3%.
Fourth quarter 2025 Comparable Hotels Adjusted Hotel EBITDA was $99.2 million, down 8.4%; full year Adjusted EBITDAre was $443.6 million, down 5.1%.
2026 guidance includes net income of $133 million to $160 million and Adjusted EBITDAre of $424 million to $447 million; preliminary January 2026 Comparable Hotels RevPAR declined approximately 1.5%.
Genworth Financial reported fourth-quarter 2025 net income available to common stockholders of $2 million, or $0 per diluted share, down from $116 million in the third quarter and a $1 million loss a year earlier. For full-year 2025, net income was $223 million, or $0.54 per diluted share, compared with $299 million in 2024, and adjusted operating income was $144 million, or $0.35 per diluted share, versus $273 million in 2024, which lowers per-share earnings for shareholders.
Q4 2025 adjusted operating income was $8 million, or $0.02 per diluted share, versus $17 million in Q3 2025 and $15 million in Q4 2024.
Q4 2025 total revenues were $1,784 million, compared with $1,782 million a year earlier and $1,935 million in Q3 2025.
Closed Block adjusted operating loss was $114 million in Q4 2025, up from $96 million in Q3 2025, with the long-term care insurance loss at $159 million.
Enact reported Q4 2025 adjusted operating income of $146 million; in February 2026, Enact announced a share repurchase program of up to $500 million.
Allison Transmission reported fourth quarter 2025 net sales of $737 million, down $59 million year over year, and net income of $99 million, down from $175 million. For full year 2025, net sales were $3.01 billion and net income was $623 million, both lower than 2024. The company also issued 2026 guidance that includes the Dana Off-Highway business, which it acquired on January 1, 2026.
Q4 2025 diluted EPS was $1.18, compared with $2.01 in Q4 2024; net income included a $29 million impairment loss and $26 million of acquisition-related expenses.
Full year 2025 diluted EPS was $7.33, compared with $8.31 in 2024; full year net sales were $3,010 million, down $215 million.
2026 guidance: consolidated net income of $600 million to $750 million and Adjusted EBITDA of $1,365 million to $1,515 million, subject to completion of purchase price accounting.
Full year 2025 repurchases totaled $328 million of common stock, representing 4 percent of outstanding shares.
Dream Finders Homes reported fourth quarter and full year 2025 results on February 23, 2026. Fourth quarter homebuilding revenues fell 24% and net income attributable to the company fell to $59 million from $129 million, while full year net sales rose 15% to 7,747 but full year net income fell to $217 million from $335 million. The company expects approximately 9,250 home closings for 2026, and shareholders will weigh that outlook against lower margins and profit.
Q4 2025 homebuilding revenues were $1.2 billion versus $1.5 billion in Q4 2024; net income attributable to DFH was $59 million ($0.60 basic per share) versus $129 million ($1.35).
Full year 2025 net income attributable to DFH was $217 million ($2.19 basic per share) versus $335 million ($3.44), while full year net sales rose 15% to 7,747.
Homebuilding gross margin was 16.7% in Q4 2025 versus 17.7% and 17.4% for the full year versus 18.3%.
The company initiated 2026 guidance of approximately 9,250 home closings.
Chemours reported a fourth-quarter 2025 net loss of $47 million, or $0.31 per diluted share, versus a $11 million loss a year earlier, on net sales of $1.3 billion, down 2%. For full year 2025, the company posted a $386 million net loss ($2.57 per diluted share) after net income of $69 million in 2024, driven by litigation-related charges. The company also guided to 2026 adjusted EBITDA of $800 million to $900 million, which shareholders can use as a benchmark for future results.
Q4 2025 net loss attributable to Chemours was $47 million, or $0.31 per diluted share, vs. a $11 million loss, or $0.08 per share, a year earlier
Q4 2025 adjusted EBITDA was $128 million, down from $168 million; full year adjusted EBITDA was $742 million vs. $768 million
Full year 2026 outlook calls for net sales growth of 3% to 5% and adjusted EBITDA of $800 million to $900 million
Sale of the former Kuan Yin TiO2 site was announced January 15, 2026, for approximately $300 million in net proceeds
Copart reported fiscal second-quarter 2026 results for the three months ended January 31, 2026, with revenue of $1.1 billion, down 3.6% from a year earlier, and net income attributable to Copart of $350.7 million, down 9.5%. Diluted earnings per share were $0.36 compared with $0.40 last year. For the six months, net income rose 0.7% to $754.4 million, while revenue fell 1.4% and diluted EPS was flat at $0.77.
Quarterly revenue was $1.1 billion, down $41.6 million or 3.6%, and gross profit was $492.8 million, down 6.2%.
Quarterly net income attributable to Copart was $350.7 million, down 9.5%, and diluted EPS was $0.36 versus $0.40.
Six-month net income attributable to Copart rose $5.0 million, or 0.7%, to $754.4 million, while six-month diluted EPS was $0.77, unchanged.
The filing reports $218.2 million of common stock repurchases in the six months ended January 31, 2026.
Employers Holdings, Inc. (NYSE: EIG) reported a fourth-quarter 2025 net loss of $23.4 million, or $1.06 per diluted share, compared with net income of $28.3 million a year earlier. For full-year 2025, net income fell to $10.8 million, or $0.46 per diluted share, from $118.6 million, and the GAAP combined ratio rose to 110.9% from 97.9%. The company also declared a $0.32 quarterly dividend and completed a $125 million share repurchase plan.
Q4 2025 net loss of $(23.4) million ($(1.06) per diluted share), versus net income of $28.3 million ($1.14 per diluted share) in Q4 2024
Full-year 2025 net income of $10.8 million ($0.46 per diluted share), versus $118.6 million ($4.71 per diluted share) in 2024
Q4 net realized and unrealized investment losses of $49.7 million, which the company says resulted from a fourth-quarter investment rebalancing
Board declared a first-quarter 2026 dividend of $0.32 per share, payable March 18, 2026, to holders of record as of March 4, 2026
ICU Medical reported fourth quarter 2025 revenue of $540.7 million, down from $629.8 million a year earlier, and a GAAP net loss of $15.7 million, smaller than the prior-year loss of $23.8 million. Adjusted diluted EPS fell to $1.91 from $2.11, and adjusted EBITDA fell to $98.2 million from $105.5 million. The company also issued fiscal 2026 guidance of GAAP net income of $26 million to $44 million and adjusted EPS of $7.75 to $8.45.
Q4 2025 revenue was $540.7 million versus $629.8 million in Q4 2024; Vital Care fell $110.3 million after the IV Solutions business was disposed of on May 1, 2025
GAAP net loss was $(15.7) million, or $(0.64) per diluted share, versus $(23.8) million, or $(0.97), a year earlier
Adjusted diluted EPS was $1.91 versus $2.11; adjusted EBITDA was $98.2 million versus $105.5 million
Fiscal 2026 guidance: GAAP net income of $26 million to $44 million; adjusted EBITDA of $400 million to $430 million; adjusted EPS of $7.75 to $8.45
Six Flags reported fourth-quarter 2025 net revenues of $650 million, down 5% from a year earlier, with attendance down 13% to 9.3 million guests. The net loss attributable to the company narrowed to $92 million, or $0.91 per diluted share, from $264 million, while Adjusted EBITDA fell to $165 million from $209 million. For the full year, the company reported a net loss attributable to shareholders of $1.60 billion, including a $1.5 billion non-cash impairment charge, and CEO John Reilly said 2025 results fell short of expectations.
Q4 2025 net revenues were $650 million, down $37 million (5%) from $687 million in Q4 2024; attendance fell 13% to 9.3 million.
Q4 2025 net loss attributable to the company was $92 million, or $0.91 per diluted share, versus a $264 million loss ($2.76 per diluted share) in Q4 2024.
Q4 2025 Adjusted EBITDA was $165 million, a $43 million decline from $209 million in Q4 2024.
Full-year 2025 net loss attributable to the company was $1.60 billion, including a $1.5 billion non-cash goodwill and intangibles impairment; net debt was $5.11 billion at Dec. 31, 2025.
PROG Holdings reported fourth-quarter 2025 revenue of $574.6 million, down 5.2% from a year earlier, and continuing-operations net earnings of $19.9 million, down from $58.3 million, a period that included a $27.8 million deferred tax benefit. The company also issued full-year and first-quarter 2026 outlook, which assumes a difficult operating environment and includes almost a full year of the recently acquired Purchasing Power business.
Q4 2025 diluted EPS from continuing operations was $0.49 versus $1.36 a year earlier; non-GAAP diluted EPS was $0.74, down 5.1% from $0.78.
Progressive Leasing GMV was $534.0 million, down 10.6%, while PROG Marketplace GMV rose 187% and Four GMV grew 126%.
Full-year 2026 outlook: total revenues of $3.02 billion to $3.14 billion and net earnings from continuing operations of $132 million to $155 million.
First-quarter 2026 outlook: total revenues of $715 million to $745 million and net earnings from continuing operations of $9 million to $17 million.
Rush Enterprises reported fiscal 2025 revenue of $7.4 billion and net income of $263.8 million, or $3.27 per diluted share, down from $7.8 billion and $304.2 million, or $3.72 per diluted share, in 2024. Fourth-quarter net income also declined to $64.3 million, or $0.81 per diluted share, from $74.8 million, or $0.91, and management said it expects industry conditions to remain challenging in the first quarter of 2026.
FY2025 revenue was $7.4 billion versus $7.8 billion in 2024; net income was $263.8 million versus $304.2 million.
Q4 2025 revenue was $1.8 billion versus $2.0 billion in Q4 2024; Q4 net income was $64.3 million, or $0.81 per diluted share, versus $0.91.
The Board declared a quarterly cash dividend of $0.19 per share, payable March 18, 2026, to holders of record as of March 3, 2026.
Management expects industry conditions to remain challenging in the first quarter of 2026 and is cautiously optimistic about the rest of the year.
Axcelis Technologies reported fourth-quarter 2025 revenue of $238.3 million, down from $252.4 million a year earlier, and diluted EPS of $1.10 versus $1.54. For the full year, revenue was $839.0 million compared with $1.02 billion in 2024, and diluted EPS was $3.80 versus $6.15. The company expects first-quarter 2026 revenue of approximately $195 million and says it continues working toward closing its pending merger with Veeco Instruments.
Q4 2025 net income was $34.3 million, versus $50.0 million in Q4 2024; GAAP diluted EPS was $1.10, versus $1.54.
Full-year 2025 revenue was $839.0 million, versus $1.02 billion in 2024; full-year GAAP diluted EPS was $3.80, versus $6.15.
Q1 2026 outlook: revenue of approximately $195 million, GAAP diluted EPS of approximately $0.38, and non-GAAP EPS of approximately $0.71.
Q4 2025 included $7.5 million of transaction and integration costs tied to the Veeco merger agreement announced October 1, 2025.
LGI Homes reported fourth-quarter 2025 home sales revenues of $474.0 million, down from $557.4 million a year earlier, and net income of $17.3 million, or $0.75 diluted EPS, versus $50.9 million, or $2.15, in the prior-year quarter. For full-year 2025, net income was $72.6 million, or $3.12 diluted EPS, compared with $196.1 million, or $8.30, in 2024. The company also issued 2026 guidance calling for 4,600 to 5,400 home closings and a gross margin of 18.0% to 20.0%, compared with 20.7% in 2025.
Q4 2025 home sales revenues were $474.0 million, versus $557.4 million in Q4 2024
Q4 2025 diluted EPS was $0.75, versus $2.15; full-year 2025 diluted EPS was $3.12, versus $8.30
2026 guidance: 4,600 to 5,400 home closings and average sales price of $355,000 to $365,000
Year-end 2025 backlog was 1,394 homes valued at $501.3 million, including a wholesale contract to deliver 480 homes during 2026
Watsco reported full-year 2025 revenue of $7.24 billion, down 5%, and diluted earnings per share of $12.25 versus $13.30 in 2024. Fourth-quarter revenue fell 10% to $1.58 billion and quarterly EPS was $1.68 versus $2.37. The board also approved a 10% increase in the annual dividend to $13.20 per share, payable starting with the April 2026 payment.
Full-year 2025 revenue $7.24 billion, down 5%; operating income $720 million, down 8%
Full-year gross profit margin rose to a record 28.0%, up 120 basis points
Fourth-quarter EPS $1.68 versus $2.37 a year earlier; operating cash flow for the quarter was a record $400 million
Annual dividend raised 10% to $13.20 per share, reflected in the April 2026 payment
Fluor reported fourth-quarter and full-year 2025 results. The fourth-quarter net loss attributable to Fluor was $1.6 billion, or $(9.87) per diluted share, compared with net earnings of $1.9 billion a year earlier, reflecting a net $2 billion reduction in the valuation of its NuScale investment. For the full year, revenue was $15.5 billion, down from $16.3 billion, and the company reported a net loss of $51 million, or $(0.31) per share, including a $643 million adverse Santos ruling.
Q4 2025 net loss attributable to Fluor of $1.6 billion, or $(9.87) per diluted share, versus net earnings of $1.9 billion, or $10.57 per share, in Q4 2024.
Full-year 2025 adjusted EPS of $2.19, down from $2.32 in 2024; operating cash flow was $(387) million versus $828 million.
Fluor set 2026 adjusted EBITDA guidance of $525 million to $585 million, compared with $504 million in 2025.
Received $1.35 billion in Q1 2026 from NuScale share sales; plans $1.4 billion in share repurchases for 2026.
Louisiana-Pacific reported fourth-quarter 2025 net sales of $567 million, down $114 million, and a net loss of $8 million, compared with net income of $63 million a year earlier. For full year 2025, net income fell $275 million to $146 million, or $2.08 per diluted share, and the company forecast full year 2026 consolidated Adjusted EBITDA of $430 million.
Q4 2025 net loss of $8 million, or $(0.11) per diluted share, versus net income of $63 million in Q4 2024; net sales fell $114 million to $567 million.
Full year 2025 net income was $146 million ($2.08 per diluted share), down $275 million; Adjusted EBITDA was $436 million, down $252 million.
2026 outlook: first quarter consolidated Adjusted EBITDA of $50 million and full year of $430 million; full year Siding net sales of about $1.7 billion.
Quarterly dividend set at $0.30 per share for Q1 2026, up from $0.28; about $1 billion total liquidity as of December 31, 2025.
Wendy's reported fourth-quarter 2025 revenue of $543.0 million, down 5.5%, and net income of $26.5 million, down 44.2%, with reported diluted EPS of $0.14 versus $0.23 a year earlier. For full-year 2026, the company expects adjusted EBITDA of $460 million to $480 million and adjusted EPS of $0.56 to $0.60, below 2025 adjusted EBITDA of $522.4 million and adjusted EPS of $0.88, and it expects global systemwide sales growth of approximately flat.
Q4 2025 global systemwide sales were $3.4 billion, down 8.3%; U.S. same-restaurant sales fell 11.3%.
Full-year 2025 net income was $165.1 million, down 15.1%, and reported diluted EPS was $0.85 versus $0.95.
2026 outlook: adjusted EBITDA $460 million to $480 million; adjusted EPS $0.56 to $0.60; free cash flow $190 million to $205 million.
No shares were repurchased in Q4 2025 or in Q1 2026 to date; about $35.0 million remains under the authorization, which expires in February 2027. The regular quarterly dividend is $0.14 per share, payable March 16, 2026.
Callaway Golf reported fourth-quarter and full-year 2025 results on February 12, 2026. Full-year net sales fell 0.8% to $2.06 billion and GAAP earnings per diluted share dropped to $0.21 from $0.50, while adjusted EBITDA from continuing operations was $222.4 million, down $38.8 million. The company guided 2026 adjusted EBITDA to $170 million to $195 million, and reported net cash of about $680 million in cash against about $480 million of debt after its Topgolf and Jack Wolfskin transactions.
Q4 2025 net sales were $367.5 million, down 1.1%, and the GAAP net loss from continuing operations was $66.0 million, or $0.36 per diluted share, versus a loss of $0.51 a year earlier.
Full-year 2025 GAAP gross margin fell to 42.1%, with $34 million of incremental tariff expense cited as the main cause.
2026 guidance calls for net sales of $1.98 billion to $2.05 billion and adjusted EBITDA of $170 million to $195 million, compared with $222 million reported for 2025.
The company announced a $200 million share repurchase program in January and plans to repay $258 million of convertible notes in May 2026.
LXP Industrial Trust reported fourth-quarter 2025 results on February 12, 2026. Gross revenues and net income attributable to common shareholders both fell from a year earlier, while Adjusted Company FFO was flat at $0.79 per diluted share. The company also issued 2026 guidance of $(0.01) to $0.14 per diluted share for net income and $3.22 to $3.37 per diluted share for Adjusted Company FFO.
Q4 2025 total gross revenues were $86.7 million, versus $100.9 million a year earlier; the filing attributes the decline mainly to $15 million of prior-year rental revenue from a tenant purchase option.
Net income attributable to common shareholders was $27.1 million, or $0.46 per diluted share, versus $31.4 million, or $0.54 per diluted share, in Q4 2024.
Adjusted Company FFO was $47.0 million, or $0.79 per diluted share, unchanged from Q4 2024.
2026 guidance: net income attributable to common shareholders of $(0.01) to $0.14 per diluted share; Adjusted Company FFO of $3.22 to $3.37 per diluted share.
Organon reported a fourth-quarter 2025 net loss of $205 million, or $0.79 per diluted share, compared with net income of $109 million, or $0.42 per share, a year earlier. The loss includes a non-cash $301 million goodwill impairment, and full-year revenue fell 3% to $6.2 billion. The company expects 2026 revenue of about $6.2 billion and Adjusted EBITDA of about $1.9 billion, both in line with 2025, while an Audit Committee review of the timing of biosimilar purchases from a supplier is underway.
Q4 2025 revenue was $1.507 billion, down 5% from $1.592 billion, and reported gross margin fell to 49.2% from 56.3%.
Full-year 2025 diluted EPS was $0.72, down from $3.33; non-GAAP Adjusted diluted EPS was $3.66, down from $4.11.
The Audit Committee review began after information was brought to its attention on February 11, 2026; the company has not determined that anything inappropriate occurred.
The Board declared a quarterly dividend of $0.02 per share, payable March 12, 2026, to holders of record on February 23, 2026.
Sylvamo reported fourth-quarter 2025 results, with net income of $33 million and diluted earnings per share of $0.83, down from $81 million and $1.94 in the same quarter of 2024. Net sales were $890 million, down from $970 million, and the company recorded an $11 million goodwill impairment in France, which reduced profit. Management said first-quarter 2026 results will be affected by lower volumes, higher energy costs and the absence of favorable one-time items, and did not give a numeric earnings outlook.
Q4 2025 net sales were $890 million versus $970 million in Q4 2024; diluted EPS was $0.83 versus $1.94.
Q4 2025 adjusted EBITDA was $125 million, a 14% margin, versus $157 million and 16% a year earlier.
Net special items were an after-tax charge of $11 million ($0.27 per diluted share), including the France goodwill impairment.
Full-year 2025 net income was $132 million versus $302 million in 2024, with free cash flow of $44 million.
NewMarket reported fourth quarter 2025 net income of $81.3 million, or $8.65 per share, down from $110.7 million, or $11.56 per share, a year earlier. For full year 2025, net income was $418.7 million, or $44.44 per share, compared with $462.4 million, or $48.22 per share, in 2024, and the company said a higher effective income tax rate was the main driver of the decline.
Q4 2025 net sales were $635.4 million, compared with $654.6 million in Q4 2024.
Q4 2025 petroleum additives operating profit was $106.8 million, compared with $135.7 million a year earlier.
Full-year 2025 specialty materials operating profit rose to $47.0 million from $17.5 million in 2024.
Full-year 2025 income tax expense was $141.8 million, compared with $121.7 million in 2024.
Noble Corporation plc reported fourth quarter 2025 revenue of $764 million, down from $798 million in the prior quarter and $927 million a year earlier, and adjusted diluted earnings per share of $0.09, down from $0.56 a year earlier. GAAP net income of $87 million was helped by a $72.8 million income tax benefit, and the company guided 2026 adjusted EBITDA to $940 million to $1.02 billion while calling 2026 a transitional year for earnings.
Q4 2025 total revenue was $764 million, versus $798 million in Q3 2025 and $927 million in Q4 2024.
Adjusted EBITDA was $232 million, versus $254 million in Q3 2025 and $319 million in Q4 2024; GAAP net income was $87 million, including a $72.8 million income tax benefit.
Adjusted diluted EPS was $0.09, versus $0.19 in Q3 2025 and $0.56 in Q4 2024; the quarter included a $22 million impairment loss.
For full year 2026, guidance calls for total revenue of $2.8 billion to $3.0 billion, adjusted EBITDA of $940 million to $1.02 billion, and capital expenditures of $590 million to $640 million; the Board approved a $0.50 per share dividend
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.